X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ALKEM LABORATORIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ALKEM LABORATORIES ALEMBIC PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 26.0 - - View Chart
P/BV x 5.9 6.2 96.2% View Chart
Dividend Yield % 0.8 0.7 112.9%  

Financials

 ALEMBIC PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
ALKEM LABORATORIES
Mar-16
ALEMBIC PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs7921,589 49.8%   
Low Rs4431,232 36.0%   
Sales per share (Unadj.) Rs167.0417.5 40.0%  
Earnings per share (Unadj.) Rs38.256.3 67.8%  
Cash flow per share (Unadj.) Rs42.064.7 64.9%  
Dividends per share (Unadj.) Rs4.0012.70 31.5%  
Dividend yield (eoy) %0.60.9 72.0%  
Book value per share (Unadj.) Rs84.9292.9 29.0%  
Shares outstanding (eoy) m188.52119.57 157.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.73.4 109.4%   
Avg P/E ratio x16.225.1 64.6%  
P/CF ratio (eoy) x14.721.8 67.4%  
Price / Book Value ratio x7.34.8 151.0%  
Dividend payout %10.522.6 46.5%   
Avg Mkt Cap Rs m116,383168,653 69.0%   
No. of employees `000NANA-   
Total wages/salary Rs m4,2149,171 45.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,48749,915 63.1%  
Other income Rs m551,645 3.3%   
Total revenues Rs m31,54251,561 61.2%   
Gross profit Rs m10,0608,482 118.6%  
Depreciation Rs m7221,006 71.8%   
Interest Rs m37671 5.5%   
Profit before tax Rs m9,3568,451 110.7%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1601,606 134.5%   
Profit after tax Rs m7,1946,731 106.9%  
Gross profit margin %31.917.0 188.0%  
Effective tax rate %23.119.0 121.5%   
Net profit margin %22.813.5 169.4%  
BALANCE SHEET DATA
Current assets Rs m15,06627,062 55.7%   
Current liabilities Rs m7,67415,324 50.1%   
Net working cap to sales %23.523.5 99.8%  
Current ratio x2.01.8 111.2%  
Inventory Days Days6767 100.7%  
Debtors Days Days4141 98.4%  
Net fixed assets Rs m8,23712,610 65.3%   
Share capital Rs m377239 157.7%   
"Free" reserves Rs m15,41634,490 44.7%   
Net worth Rs m16,00535,027 45.7%   
Long term debt Rs m01,212 0.0%   
Total assets Rs m24,59454,387 45.2%  
Interest coverage x255.213.6 1,876.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.9 139.5%   
Return on assets %29.413.6 216.0%  
Return on equity %44.919.2 233.9%  
Return on capital %58.724.9 236.1%  
Exports to sales %55.712.9 430.6%   
Imports to sales %10.43.1 337.9%   
Exports (fob) Rs m17,5516,461 271.6%   
Imports (cif) Rs m3,2831,540 213.1%   
Fx inflow Rs m17,8116,563 271.4%   
Fx outflow Rs m5,3183,012 176.6%   
Net fx Rs m12,4933,552 351.7%   
CASH FLOW
From Operations Rs m9,3047,259 128.2%  
From Investments Rs m-3,1051,864 -166.5%  
From Financial Activity Rs m-1,959-9,273 21.1%  
Net Cashflow Rs m4,240-150 -2,826.7%  

Share Holding

Indian Promoters % 74.1 66.9 110.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 33.1 8.8%  
FIIs % 9.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 0.0 -  
Shareholders   49,328 68,381 72.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Strong; Consumer Durables Stocks Drag(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are trading above the dotted line. Except stocks in the consumer durables sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS